Llwytho...
Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome
Haemolytic uraemic syndrome (HUS) remains a leading cause of paediatric acute kidney injury (AKI). Haemolytic uraemic syndrome is characterised by the triad of microangiopathic haemolytic anaemia, thrombocytopenia and AKI. In ~ 90% of cases, HUS is a consequence of infection with Shiga toxin-produci...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pediatr Nephrol |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Springer Berlin Heidelberg
2018
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6660499/ https://ncbi.nlm.nih.gov/pubmed/30058046 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00467-018-4025-0 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|